TipRanks
Advertisement
Advertisement

DE:APE1 Stock Latest News

Addex Therapeutics spin-out company completes NTX-253 clinical studies
The FlyAddex Therapeutics spin-out company completes NTX-253 clinical studies
6d ago
ADXN
Addex Therapeutics announces publication of new ADX71743 preclinical research
PremiumThe Fly
Addex Therapeutics announces publication of new ADX71743 preclinical research
3M ago
ADXN
Addex Therapeutics announces GABAB PAM candidate data
PremiumThe Fly
Addex Therapeutics announces GABAB PAM candidate data
6M ago
ADXN
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2
PremiumThe Fly
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2
6M ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading resumes
7M ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
PremiumThe FlyAddex Therapeutics Ltd – ADR trading halted, volatility trading pause
7M ago
ADXN
Addex publishes negative allosteric modulators data in Molecular Psychiatry
Premium
The Fly
Addex publishes negative allosteric modulators data in Molecular Psychiatry
8M ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
Premium
The Fly
Addex Therapeutics Ltd – ADR trading resumes
9M ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
9M ago
ADXN
Addex Therapeutics spin-out Neurosterix starts NTX-253 study
PremiumThe Fly
Addex Therapeutics spin-out Neurosterix starts NTX-253 study
9M ago
ADXN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges
PremiumCompany Announcements
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges
10M ago
ADXN
Addex Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Addex Therapeutics Reports Q3 2025 Financial Results
10M ago
ADXN
Addex Therapeutics files to sell $150M in ordinary shares
PremiumThe FlyAddex Therapeutics files to sell $150M in ordinary shares
11M ago
ADXN
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges
Premium
Company Announcements
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges
1y ago
ADXN
Addex Therapeutics Reports Significant Loss Amid Financial Challenges
Premium
Company Announcements
Addex Therapeutics Reports Significant Loss Amid Financial Challenges
1y ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading resumes
1y ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
1y ago
ADXN
Addex Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Addex Therapeutics Reports Q1 2025 Financial Results
1y ago
ADXN
Addex reports anti-tussive activity of GABAB positive allosteric modulator
PremiumThe Fly
Addex reports anti-tussive activity of GABAB positive allosteric modulator
1y ago
ADXN
Addex Therapeutics enters collaboration with Sinntaxis AB
PremiumThe FlyAddex Therapeutics enters collaboration with Sinntaxis AB
1y ago
ADXN
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges
Premium
Company Announcements
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges
1y ago
ADXN
Addex Therapeutics Reports Strong 2024 Financial Turnaround
Premium
Company Announcements
Addex Therapeutics Reports Strong 2024 Financial Turnaround
1y ago
ADXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >